Neurodegenerative disorders and ischemic brain diseases

Apoptosis

Volumn 6, Issue 1-2, 2001, Pages 69-81

  Mattson, M P ^a   Duan, W ^a   Pedersen, W A ^a   Culmsee, C ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

Alzheimer's disease; Caspases; Mitochondrial permeability transition; Neurotrophic factors; Oxidative stress; Parkinson's disease; Telomerase

Indexed keywords

AMYLOID PRECURSOR PROTEIN; PRESENILIN 1;

ALZHEIMER DISEASE; APOPTOSIS; BRAIN ISCHEMIA; DEGENERATIVE DISEASE; HEAD INJURY; HUMAN; NERVE CELL DEGENERATION; PARKINSON DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; STROKE;

APOPTOSIS; BRAIN ISCHEMIA; HUMANS; NEURODEGENERATIVE DISEASES; SIGNAL TRANSDUCTION;

EID: 0035078659     PISSN: 13608185     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1009676112184     Document Type: Review

References (150)

1. The burden of dementia. A medical and research perspective
2. Parkinson's disease and the U.S. health care system
3. Risk factors and their management for stroke prevention: Outlook for 1999 and beyond
4. Cellular and molecular mechanisms underlying perturbed energy metabolism and neuronal degeneration in Alzheimer's and Parkinson's diseases
5. Understanding cell death in Parkinson's disease
6. Modification of ion homeostasis by lipid peroxidation: Roles in neuronal degeneration and adaptive plasticity
7. Pathobiology of ischaemic stroke: An integrated view
8. Ischemic cell death in brain neurons
9. Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice
10. Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein
11. Increased amyloid-b42(43) in brains of mice expressing mutant presenilin 1
12. Increased vulnerability of hippocampal neurons to excitotoxic necrosis in presenilin-1 mutant knockin mice
13. Stress exacerbates neuron loss and cytoskeletal pathology in the hippocampus
14. Aging renders the brain vulnerable to amyloid b-protein neurotoxicity
15. Participation of prostate apoptosis response-4 in degeneration of dopaminergic neurons in models of Parkinson's disease
16. Neuroprotective effects of gelsolin during murine stroke
17. Alzheimer's disease: Etiologies, pathophysiology, cognitive reserve, and treatment opportunities
18. Cellular actions of β-amyloid precursor protein, and its soluble and fibrillogenic peptide derivatives
19. Amyloid, the presenilins and Alzheimer's disease
20. Presenilins, the endoplasmic reticulum, and neuronal apoptosis in Alzheimer's disease
21. Cellular and molecular mechanisms underlying perturbed energy metabolism and neuronal degeneration in Alzheimer's and Parkinson's diseases
22. Oxidative stress and a key metabolic enzyme in Alzheimer brains, cultured cells, and an animal model of chronic oxidative deficits
23. Active site-directed antibodies identify calpain II as an early-appearing and pervasive component of neurofibrillary pathology in Alzheimer's disease
24. Alterations in the ryanodine receptor calcium release channel correlate with Alzheimer's disease neurofibrillary and beta-amyloid pathologies
25. Calcium signaling in the ER: Its role in neuronal plasticity and neurodegenerative disorders
26. β-amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity
27. Neurotrophic factors [activity-dependent neurotrophic factor (ADNF) and basic fibroblast growth factor (bFGF)] interrupt excitotoxic neurodegenerative cascades promoted by a presenilin-1 mutation
28. Nerve growth factor and its receptors in the primate forebrain: Alterations in Alzheimer's disease and potential use in experimental therapeutics
29. BDNF mRNA is decreased in the in the hippocampus of individuals with Alzheimer's disease
30. Neuritic involvement within bFGF immunopositive plaques of Alzheimer's disease
31. Transforming growth factor-β1 is in plaques in Alzheimer and Down pathologies
32. Calcium-destabilizing and neurodegenerative effects of aggregated β-amyloid peptide are attenuated by basic FGF
33. Cellular signaling roles of TGFβ, TNFα and βAPP in brain injury responses and Alzheimer's disease
34. Evidence for apoptotic cell death in Alzheimer's disease
35. Immunocytochemical evidence for apoptosis in Alzheimer's disease
36. Caspase dependent DNA fragmentation might be associated with excitotoxicity in Alzheimer disease
37. Evidence for caspase-mediated cleavage of AMPA receptor subunits in neuronal apoptosis and in Alzheimer's disease
38. GADD45 is induced in Alzheimer's disease, and protects against apoptosis in vitro
39. Bcl-2 and Bax protein expression in Alzheimer's disease
40. Par-4 is a mediator of neuronal degeneration associated with the pathogenesis of Alzheimer's disease
41. Apoptosis is induced by β-amyloid in cultured central nervous system neurons
42. 2+ homeostasis and cell death
43. Evidence that 4-hydroxynonenal mediates oxidative stress-induced neuronal apoptosis
44. Secreted APPα counteracts the pro-apoptotic action of mutant presenilin-1 by activation of NF-κB and stabilization of calcium homeostasis
45. Alzheimer's presenilin mutation sensitizes neural cells to apoptosis induced by trophic factor withdrawal and amyloid β-peptide: Involvement of calcium and oxyradicals
46. Increased vulnerability of hippocampal neurons from presenilin-1 mutant knock-in mice to amyloid β-peptide toxicity: Central roles of superoxide production and caspase activation
47. Presenilin-1 mutations increase levels of ryanodine receptors and calcium release in PC12 cells and cortical neurons
48. "Apoptotic" biochemical cascades in synaptic compartments: Roles in adaptive plasticity and neurodegenerative disorders
49. Evidence for synaptic apoptosis
50. Amyloid β-peptide induces apoptosis-related events in synapses and dendrites
51. Beta-amyloid induces local neurite degeneration in cultured hippocampal neurons: Evidence for neuritic apoptosis
52. Impairment of glucose and glutamate transport and induction of mitochondrial oxidative stress and dysfunction in synaptosomes by amyloid β-peptide: Role of the lipid peroxidation product 4-hydroxynonenal
53. Amyloid β-peptide impairs glucose uptake in hippocampal and cortical neurons: Involvement of membrane lipid peroxidation
54. Prostate apoptosis response-4 production in synaptic compartments following apoptotic and excitotoxic insults: Evidence for a pivotal role in mitochondrial dysfunction and neuronal degeneration
55. Altered calcium homeostasis and mitochondrial dysfunction in cortical synaptic compartments of presenilin-1 mutant mice
56. Caspase-mediated degradation of AMPA receptor subunits: A mechanism for preventing excitotoxic necrosis and ensuring apoptosis
57. Understanding cell death in Parkinson's disease
58. Mitochondria in the etiology and pathogenesis of Parkinson's disease
59. Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease
60. A generalised increase in protein carbonyls in the brain in Parkinson's but not incidental Lewy body disease
61. Oxidative DNA damage in the parkinsonian brain: An apparent selective increase in 8-hydroxyguanine in substantia nigra
62. Mitochondrial complex I deficiency in Parkinson's disease
63. Mitochondrial DNA transmission of the mitochondrial defect in Parkinson's disease
64. Epidemiology versus genetics in Parkinson's disease: Progress in resolving an age-old debate
65. Selective loss of sub-populations of ventral mesencephalic dopaminergic neurons in the monkey following exposure to MPTP
66. Effects of different schedules of MPTP administration on dopaminergic neurodegeneration in mice
67. Autosomal dominant Parkinson's disease and alpha-synuclein
68. The AMPA receptor antagonist NBQX has antiparkinsonian effects in monoamine-depleted rats and MPTP-treated monkeys
69. Increased iron in the substantia nigra compacta of the MPTP-lesioned hemi-parkinsonian African green monkey: Evidence from proton microprobe elemental microanalysis
70. Inhibition of neuronal nitric oxide synthase prevents MPTP-induced parkinsonism in baboons
71. Histochemical detection of apoptosis in Parkinson's disease
72. A fluorescent double-labeling method to detect and confirm apoptotic nuclei in Parkinson's disease
73. In situ detection of apoptotic nuclei in the substantia nigra compacta of 1-methyl-4-phenyl-1, 2,3,6-tetrahydropyridine-treated mice using terminal deoxynucleotidyl transferase labelling and acridine orange staining
74. P53-and CD95-associated apoptosis in neurodegenerative diseases
75. Increase in bax expression in substantia nigra following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) treatment of mice
76. Involvement of a caspase-3-like cysteine protease in 1-methyl-4-phenylpyridinium-mediated apoptosis of cultured cerebellar granule neurons
77. 1-Methyl-4-phenylpyridinium (MPP+)-induced cell death in PC12 cells: Inhibitory effects of several drugs
78. Pathobiology of ischaemic stroke: An integrated view
79. Further evolution toward effective therapy for acute ischemic stroke
80. The temporal profile and morphologic features of neuronal death in human stroke resemble those observed in experimental forebrain ischemia: The potential role of apoptosis
81. Apoptosis and expression of DNA repair proteins in ischaemic brain injury in man
82. Intrathecal expression of proteins regulating apoptosis in acute stroke
83. Evidence supporting a role for programmed cell death in focal cerebral ischemia in rats
84. Mitochondrial susceptibility to oxidative stress exacerbates cerebral infarction that follows permanent focal cerebral ischemia in mutant mice with manganese superoxide dismutase deficiency
85. Cytosolic redistribution of cytochrome c after transient focal cerebral ischemia in rats
86. Mitochondrial manganese superoxide dismutase prevents neural apoptosis and reduces ischemic brain injury: Suppression of peroxynitrite production, lipid peroxidation, and mitochondrial dysfunction
87. Blockade of the mitochondrial permeability transition pore diminishes infarct size in the rat after transient middle cerebral artery occlusion
88. Expression of bcl-2 from a defective herpes simplex virus-1 vector limits neuronal death in focal cerebral ischemia
89. Presenilin-1 mutation increases neuronal vulnerability to focal ischemia in vivo and to hypoxia and glucose deprivation in cell culture: Involvement of perturbed calcium homeostasis
90. Expression of interleukin-1 beta converting enzyme gene family and bcl-2 gene family in the rat brain following permanent occlusion of the middle cerebral artery
91. Caspase-8 and caspase-3 are expressed by different populations of cortical neurons undergoing delayed cell death after focal stroke in the rat
92. Inhibition of interleukin 1 beta converting enzyme family proteases reduces ischemic and excitotoxic neuronal damage
93. Attenuation of delayed neuronal death after mild focal ischemia in mice by inhibition of the caspase family
94. Reduced ischemic brain injury in interleukin-1 beta converting enzyme-deficient mice
95. Hippocampal Myc and p53 expression following transient global ischemia
96. Bcl-x(1) Bax interaction after transient global ischemia
97. Increases in DNA lesions and the DNA damage indicator Gadd45 following transient cerebral ischemia
98. CD95 ligand (Fas-L/APO-1L) and tumor necrosis factor-related apoptosis-inducing ligand mediate ischemia-induced apoptosis in neurons
99. Hypoxia/reoxygenation induces apoptosis through biphasic induction of protein synthesis in cultured rat brain neurons
100. NGF and bFGF protect rat and human central neurons against hypoglycemic damage by stabilizing calcium homeostasis
101. Caspase-mediated degradation of AMPA receptor subunits: A mechanism for preventing excitotoxic necrosis and ensuring apoptosis
102. Evidence that 4-hydroxynonenal mediates oxidative stress-induced neuronal apoptosis
103. Par-4 mediates trophic factor withdrawal-induced apoptosis of hippocampal neurons: Actions prior to mitochondrial dysfunction and caspase activation
104. Evidence for involvement of Par-4 in ischemic neuronal death
105. Growth factors prevent mitochondrial dysfunction, loss of calcium homeostasis and cell injury, but not ATP depletion in hippocampal neurons deprived of glucose
106. Mitochondrial depolarization in glutamate stimulated neurons: An early signal specific to excitotoxin exposure
107. Nitric oxide induces apoptosis via triggering mitochondrial permeability transition
108. Role of caspases in N-methyl-D-aspartate-induced apoptosis in cerebrocortical neurons
109. Sequential activation of activator protein-1-related transcription factors and JNK protein kinases may contribute to apoptotic death induced by transient hypoxia in developing brain neurons
110. The lipid peroxidation product 4-hydroxy-2,3-nonenal increases AP-1-binding activity through caspase activation in neurons
111. Pivotal role for acidic sphingomyelinase in cerebral ischemia-induced ceramide and cytokine production, and neuronal apoptosis
112. Reduced fertility and postischaemic brain injury in mice deficient in cytosolic phospholipase A2
113. Programmed cell life: Anti-apoptotic signaling and therapeutic strategies for neurodegenerative disorders
114. IGF-I and IGF-II protect cultured hippocampal and septal neurons against calcium-mediated hypoglycemic damage
115. NT-3 and BDNF protect CNS neurons against metabolic/excitotoxic insults
116. PDGFs protect hippocampal neurons against energy deprivation and oxidative injury: Evidence for induction of antioxidant pathways
117. Neurotrophic factors protect synaptic terminals against amyloid-and oxidative stress-induced impairment of glucose transport, glutamate transport and mitochondrial function
118. Evidence for excitoprotective and intraneuronal calcium-regulating roles for secreted forms of β-amyloid precursor protein
119. Tumor necrosis factors protect neurons against excitotoxic/metabolic insults and promote maintenance of calcium homeostasis
120. Secreted forms of β-amyloid precursor protein protect against ischemic brain injury
121. Altered neuronal and microglial responses to brain injury in mice lacking TNF receptors
122. 2+]i and neurotoxicity, and increase antioxidant enzyme activities in hippocampal neurons
123. 2+ responses to AMPA and NMDA in hippocampal neurons
124. Differential effects of BDNF, ADNF9, and TNFalpha on levels of NMDA receptor subunits, calcium homeostasis, and neuronal vulnerability to excitotoxicity
125. 2+ accumulation
126. Induction of neuroprotective κB-dependent transcription by secreted forms of the Alzheimer's β-amyloid precursor
127. Activation of NF-κB protects hippocampal neurons against oxidative stress-induced apoptosis: Evidence for induction of Mn-SOD and suppression of peroxynitrite production and protein tyrosine nitration
128. Lack of the p50 subunit of NF-κB increases the vulnerability of hippocampal neurons to excitotoxic injury
129. Tumor necrosis factor induces Bcl-2 and Bcl-x expression through NF-κB activation in primary hippocampal neurons
130. The actin-severing protein gelsolin modulates calcium channel and NMDA receptor activities and vulnerability to excitotoxicity in hippocampal neurons
131. Neuroprotective effects of gelsolin during murine stroke
132. Transgenic mice expressing the human inducible Hsp70 have hippocampal neurons resistant to ischemic injury
133. Dietary restriction and 2-deoxyglucose administration reduce focal ischemic brain damage and improve behavioral outcome: Evidence for a preconditioning mechanism
134. The endoplasmic reticulum stress-responsive protein GRP78 protects neurons against excitotoxicity and apoptosis: Suppression of oxidative stress and stabilization of calcium homeostasis
135. Ischemic preconditioning and brain tolerance: Temporal histological and functional outcomes, protein synthesis requirement, and interleukin-1 receptor antagonist and early gene expression
136. Oxidative stress, caloric restriction, and aging
137. Dietary lipids and antioxidants in Parkinson's disease: A population-based, case-control study
138. Reduced risk of Alzheimer's disease among individuals with low calorie intake
139. Primary prevention of stroke
140. Food restriction reduces brain damage and improves behavioral outcome following excitotoxic and metabolic insults
141. Dietary restriction protects hippocampal neurons against the death-promoting action of a presenilin-1 mutation
142. Dietary restriction and 2-deoxyglucose administration improve behavioral outcome and reduce degeneration of dopaminergic neurons in models of Parkinson's disease
143. Environmental enrichment inhibits spontaneous apoptosis, prevents seizures and is neuroprotective
144. Physical activity increases mRNA for brain-derived neurotrophic factor and nerve growth factor in rat brain
145. Mammalian neural stem cells
146. Multipotent neural precursors can differentiate toward replacement of neurons undergoing targeted apoptotic degeneration in adult mouse neocortex
147. Telomerase activity, cell proliferation, and cancer
148. The catalytic subunit of telomerase is expressed in developing brain neurons and serves a cell survival-promoting function
149. Anti-apoptotic role of telomerase in pheochromocytoma cells
150. The catalytic subunit of telomerase protects neurons against amyloid β-peptide-induced apoptosis